文献
J-GLOBAL ID:202102246191436274
整理番号:21A0096158
ナパブカシンは癌幹細胞性を阻害することにより卵巣胚細胞腫瘍由来細胞株においてシスプラチン耐性を克服する【JST・京大機械翻訳】
Napabucasin overcomes cisplatin resistance in ovarian germ cell tumor-derived cell line by inhibiting cancer stemness
著者 (22件):
Schmidtova Silvia
(Department of Molecular Oncology, Cancer Research Institute, Biomedical Research Center, University Science Park for Biomedicine, Slovak Academy of Sciences, Bratislava, Slovakia)
,
Schmidtova Silvia
(Translational Research Unit, Faculty of Medicine, Comenius University, Bratislava, Slovakia)
,
Dorssers Lambert C. J.
(Department of Pathology, Laboratory for Experimental Patho-Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands)
,
Kalavska Katarina
(Department of Molecular Oncology, Cancer Research Institute, Biomedical Research Center, University Science Park for Biomedicine, Slovak Academy of Sciences, Bratislava, Slovakia)
,
Kalavska Katarina
(Translational Research Unit, Faculty of Medicine, Comenius University, Bratislava, Slovakia)
,
Kalavska Katarina
(2nd Department of Oncology, Faculty of Medicine, Comenius University and National Cancer Institute, Bratislava, Slovakia)
,
Gillis Ad J. M.
(Department of Pathology, Laboratory for Experimental Patho-Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands)
,
Gillis Ad J. M.
(Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands)
,
Oosterhuis J. Wolter
(Department of Pathology, Laboratory for Experimental Patho-Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands)
,
Stoop Hans
(Department of Pathology, Laboratory for Experimental Patho-Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands)
,
Miklikova Svetlana
(Department of Molecular Oncology, Cancer Research Institute, Biomedical Research Center, University Science Park for Biomedicine, Slovak Academy of Sciences, Bratislava, Slovakia)
,
Kozovska Zuzana
(Department of Molecular Oncology, Cancer Research Institute, Biomedical Research Center, University Science Park for Biomedicine, Slovak Academy of Sciences, Bratislava, Slovakia)
,
Burikova Monika
(Department of Molecular Oncology, Cancer Research Institute, Biomedical Research Center, University Science Park for Biomedicine, Slovak Academy of Sciences, Bratislava, Slovakia)
,
Gercakova Katarina
(Department of Molecular Oncology, Cancer Research Institute, Biomedical Research Center, University Science Park for Biomedicine, Slovak Academy of Sciences, Bratislava, Slovakia)
,
Durinikova Erika
(Department of Molecular Oncology, Cancer Research Institute, Biomedical Research Center, University Science Park for Biomedicine, Slovak Academy of Sciences, Bratislava, Slovakia)
,
Chovanec Michal
(Translational Research Unit, Faculty of Medicine, Comenius University, Bratislava, Slovakia)
,
Chovanec Michal
(2nd Department of Oncology, Faculty of Medicine, Comenius University and National Cancer Institute, Bratislava, Slovakia)
,
Mego Michal
(Translational Research Unit, Faculty of Medicine, Comenius University, Bratislava, Slovakia)
,
Mego Michal
(2nd Department of Oncology, Faculty of Medicine, Comenius University and National Cancer Institute, Bratislava, Slovakia)
,
Kucerova Lucia
(Department of Molecular Oncology, Cancer Research Institute, Biomedical Research Center, University Science Park for Biomedicine, Slovak Academy of Sciences, Bratislava, Slovakia)
,
Looijenga Leendert H. J.
(Department of Pathology, Laboratory for Experimental Patho-Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands)
,
Looijenga Leendert H. J.
(Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands)
資料名:
Cancer Cell International (Web)
(Cancer Cell International (Web))
巻:
20
号:
1
ページ:
1-16
発行年:
2020年
JST資料番号:
U7315A
ISSN:
1475-2867
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
イギリス (GBR)
言語:
英語 (EN)